Results

Menu

Publications

Academia and industry agreement on a feasibility tool for first‐time‐in‐human clinical trial units

Implementing best practices on data generation and reporting of Mycobacterium tuberculosis in vitro assays within the ERA4TB consortium

Microfluidic dose–response platform to track the dynamics of drug response in single mycobacterial cells

Publications related to relevant scientific background of ERA4TB

Difference in persistent tuberculosis bacteria between in vitro and sputum from patients: implications for translational predictions

A lung-on-chip model of early Mycobacterium tuberculosis infection reveals an essential role for alveolar epithelial cells in controlling bacterial growth

Deliverables

D1.12 Second Report on clinical and preclinical datasets standardized and integrated into the DDIM

D4.2 Implementation of PK/PD MALDI-MS imaging to analyses infected tissue

D2.1. Implementation of HFS-TB in a BSL3 setting in Europe

D1.10 First Report on clinical and preclinical datasets standardized and integrated into the DDIM

D1.3 Instantiation of EU-based Drug Development Information Management (DDIM) system

D1.4 Initial standardized data templates for collection and reporting of clinical and preclinical data available to Consortium members

D1.8 Standardized templates for collection and reporting of clinical and preclinical data available to consortium members –Interim reportD1.6 Availability of existing preclinical and clinical TB datasets – Interim Report

D1.6 Availability of existing preclinical and clinical TB datasets – Interim Report

D3.1 First Report on implementation of selected mouse models for in vivo evaluation of drug candidates

D8.1 Project Handbook

D8.4 Project Communication Plan

Know how accelerate the development of new treatment regimens for tuberculosis, discover our project

The Project